Eliminating Hepatitis C Transmission By Enhancing Hepatitis C Care And Treatment In Primary Health Care Settings.
Funder
National Health and Medical Research Council
Funding Amount
$1,221,831.00
Summary
In developed countries, people who inject drugs (PWID) are the group at greatest risk of hepatitis C (HCV) infection but few PWID receive HCV treatment. With the advent of highly effective non-interferon based treatments HCV elimination, although ambitious, is now being seriously considered globally. This partnership grant will explore the feasibility of eliminating HCV transmission by enhancing HCV care and treatment for PWID in primary health care settings.
The Extended Australian Workplace Exposures Study - AWES2
Funder
National Health and Medical Research Council
Funding Amount
$541,293.00
Summary
Work-related asthma and cancer are largely preventable conditions, but we need to understand the risks faced by workers in order to direct prevention policy and practice. We will survey 5000 Australian workers to estimate the exposure to asthma- and cancer-causing agents in the workplace. This partnership between university researchers and government and non-government organisations will provide a sound basis for determining how to decrease the number of these occupational diseases.